Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer - sprookjes - yvandenbroek - TriplyDB

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

http://www.wikidata.org/entity/Q28278736

about

Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cells Recent advances of novel targeted therapy in non-small cell lung cancer Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for Update in lung cancer 2007 Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery Predicting clinical trial results based on announcements of interim analyses Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and Future Molecular biology of lung cancer: clinical implications Nedaplatin: a cisplatin derivative in cancer chemotherapy Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer Reinforcement learning design for cancer clinical trials Characterizing the cancer genome in lung adenocarcinoma.EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer Optimizing the management of advanced non-small-cell lung cancer: a personal view Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501 New molecularly targeted therapies for lung cancer New advances in targeted gastric cancer treatment Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics Pazopanib in the management of advanced soft tissue sarcomas Tumor refractoriness to anti-VEGF therapy Gene aberrations for precision medicine against lung adenocarcinoma Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes Vascular Complications of Cancer Chemotherapy Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinoma Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions Profile of bevacizumab and its potential in the treatment of cervical cancer Personalized medicine in gastric cancer: Where are we and where are we going?

P2860

Q21090858-457DAE70-3E5B-4F79-BC6A-C4D77FCE03BC Q21092930-713BF1E3-5257-47A8-ABA1-4A3F2BD67624 Q21132534-21BBA18E-2792-407E-A4F7-94640CC16E43 Q21261297-54AADD3F-5A71-4D64-B08D-9809E3A121A8 Q22241904-54507717-EDC4-48AC-89AE-C2D6AFBCEF20 Q24186464-10737197-AA1C-47BA-A9E6-BEF617AC9E88 Q24200413-856A8852-1048-4A88-9EB2-7763FAFDBFD2 Q24200772-76E6EBD2-57FA-4035-866D-552B79F9C04B Q24288918-7B44D812-0927-4A76-AD59-01102ADFA436 Q24318418-84ACC473-0679-4DB1-B4D0-05C9EB0CF214 Q24564024-A44ED486-CA8F-4679-A70A-EA203639C77D Q24610335-68FDAF53-B4D1-40E1-9C14-47D34B22F3D0 Q24623561-3832A09D-7DE4-4367-89AA-8CC9F2A14C8C Q24632703-90A3C4AF-9B94-487B-9D74-93B86F4EE9B8 Q24642049-0127679C-961C-468C-8228-3CD14F235E8A Q24648505-5E21E3BA-8C6B-43AC-A77F-FDEABC48ED47 Q24649926-9945DDC5-339B-4FDF-BB38-4A76F2B1E5B0 Q24652337-5AD7206E-AD29-4335-945F-F9747D2F207D Q24652733-7C420822-14B1-4E4B-8B13-768A674AEE05 Q24656144-A10B3F06-01BF-4E40-84D4-4E7F35883806 Q24657761-2DDC70E4-2831-40C4-BEB1-A36F4342F38D Q24658198-EFE53298-5E7A-4886-A21D-CE5221A5FDE5 Q24680988-093A915D-BE5B-4FAE-9C8C-2D340BEDC9B0 Q26738548-5B054610-2CBD-40CC-A1F8-E353536F0F9D Q26740812-DE01F903-A2F6-4A3A-8C73-2246719C694B Q26742107-A8B82E4D-9F29-44D9-9AF7-7FD72789F34F Q26744339-73A7F3DA-5032-4223-A577-E75734727398 Q26746067-CE61A6C1-0940-4280-9A9E-4F6DACC2FF9D Q26746205-51C6258C-4695-464D-B909-1337657AD5CC Q26747678-768CCC8C-477A-49D4-BBE7-BE85A0F9E05A Q26749348-6BB22804-5B4D-4F96-B17F-E286A59A2382 Q26750715-CD91D74D-E46D-49AA-9531-4A7E3534C876 Q26766180-F2C09D98-EFC4-4611-A3ED-A356849E76FE Q26766269-0A6166E5-D262-471D-ADA4-8592273CFCB4 Q26767182-BB57FB3D-5300-467A-8A99-E57984655BE6 Q26768267-77914A56-D92F-40A5-9506-65EEC1B3DC26 Q26769884-9AF9ED9F-B5F2-4C22-94D9-5F773B3A8D6C Q26770254-55243BAC-003F-4681-AC10-0D49A457261C Q26774168-1F4D4F49-D6EC-46B0-B356-D7C4E8DD28EB Q26774521-B006A784-A586-4164-B9D9-CE9E441B4C8C

P2860

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

http://www.wikidata.org/entity/Q28278736

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@ast

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@en

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@nl

type

label

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@ast

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@en

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@nl

prefLabel

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@ast

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@en

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@nl

P1433

Q28278736-C3B703BC-EBC2-4DC7-A850-5CF202674CBD

P1476

Q28278736-61947745-72EF-4B15-AF46-79D7AF59BF0F

P2093

Q28278736-288DBCBD-D725-4BE9-BBCE-DA46FAEB222B

Q28278736-390205CD-E1FA-41B7-9DA2-7A5F9291E15D

Q28278736-496BC995-79E9-4F9C-8615-1CF65426EFB1

Q28278736-4C29BCD8-1C6A-43BF-81BD-7DB7B73C0B67

Q28278736-56D465EF-BBD6-49F3-BCC0-D70EA8871B1E

Q28278736-72696AD1-1BD3-4F64-857C-87421D33E396

Q28278736-7EC5494C-210A-4CFB-BAC2-381901F86EDD

Q28278736-9C73B5FB-2F86-49EF-991B-18247B854E13

P304

Q28278736-B64BC8F8-CCA7-4257-93BD-03A2042F7EB1

P31

Q28278736-76D50F5F-99B5-4D45-820E-E281E4952A91

P3181

Q28278736-0AD05BD4-3891-4B2D-A655-CD5A78CAB6A6

P356

Q28278736-A44FD7FD-0DE7-4F76-B9FA-1DCBA5B67F79

P407

Q28278736-3703CC47-B99F-4A72-BC3C-F45DD57EB333

P433

Q28278736-D9FB9C6B-B676-42FF-89C9-1E0C8B786927

P478

Q28278736-A5BADEDD-7621-4C64-9993-0B83EDA19665

P577

Q28278736-18A5C6A8-AF49-4FF3-98AB-37D4BC42FF35

P5875

Q28278736-E094800C-EC1C-463B-B6D8-AD64BA0F1B0F

P698

Q28278736-6BF65C8F-3ABD-4B47-A2D8-D0289DEE2C52

P921

Q28278736-F59E577D-543B-47AC-8F40-4BE2C3B15A74

P3181

P356

P1433

The New England Journal of Medicine

P1476

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

@en

P2093

Afshin Dowlati

http://www.w3.org/2001/XMLSchema#string

Alan Sandler

http://www.w3.org/2001/XMLSchema#string

David H Johnson

http://www.w3.org/2001/XMLSchema#string

Joan H Schiller

http://www.w3.org/2001/XMLSchema#string

Julie Brahmer

http://www.w3.org/2001/XMLSchema#string

Michael C Perry

http://www.w3.org/2001/XMLSchema#string

Robert Gray

http://www.w3.org/2001/XMLSchema#string

Rogerio Lilenbaum

http://www.w3.org/2001/XMLSchema#string

P304

2542-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

349799

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA061884

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6633141

http://www.w3.org/2001/XMLSchema#string

P698

17167137

http://www.w3.org/2001/XMLSchema#string

P921